Foretellix Accelerates AI-Powered Autonomous Vehicles with Data-Driven Development Toolchain and Safety Evaluation
Data-driven verification and validation pioneers pave the safest and quickest route to driverless mobility with generation of high-fidelity sensor data that leverages NVIDIA Omniverse and Cosmos SAN FRANCISCO and TEL AVIV, Israel, May 21, 2025...
Full Truck Alliance Co. Ltd. Announces First Quarter 2025 Unaudited Financial Results
GUIYANG, China, May 21, 2025 /PRNewswire/ -- Full Truck Alliance Co. Ltd. ("FTA" or the "Company") (NYSE: YMM), a leading digital freight platform, today announced its unaudited financial results for the first quarter ended March 31, 2025. First...
Weibo Announces First Quarter 2025 Unaudited Financial Results
BEIJING, May 21, 2025 /PRNewswire/ -- Weibo Corporation ("Weibo" or the "Company") (Nasdaq: WB and HKEX: 9898), a leading social media in China, today announced its unaudited financial results for the first quarter ended March 31, 2025. "We are...
Baidu Announces First Quarter 2025 Results
BEIJING, May 21, 2025 /PRNewswire/ -- Baidu, Inc. (NASDAQ: BIDU and HKEX: 9888 (HKD Counter) and 89888 (RMB Counter)) ("Baidu" or the "Company"), a leading AI company with a strong Internet foundation, today announced its unaudited financial results...
Fukuoka City Announces Fukuoka Prize 2025 Laureates
-Grand Prize Awarded to TAKARA Kurayoshi, Japanese Historian- FUKUOKA, Japan, May 21, 2025 /PRNewswire/ -- Fukuoka City (Secretariat of Fukuoka Prize Committee) on Wednesday May 21 announced the laureates for the Fukuoka Prize 2025 designed to honor...
LABUAN IBFC INC. ANNOUNCES APPOINTMENT OF NEW CHAIRMAN AND MEMBER OF THE BOARD
KUALA LUMPUR, Malaysia, May 21, 2025 /PRNewswire/ -- Mr. Steven Choy Khai Choon has been appointed as Chairman, and Dr. Aida Othman as a member of the Board of Directors of Labuan IBFC Incorporated Sdn Bhd (Labuan IBFC Inc.). Both appointments,...
Accropeutics Announces Positive Data from Phase 2 Trial of AC-201, an oral, selective TYK2/JAK1 Inhibitor, for the treatment of Moderate-to-Severe Plaque Psoriasis
Phase 2 primary endpoint of PASI-75 and key secondary endpoints met in all of the three dosing groups at Week 12 AC-201 was generally well tolerated at all dose levels with no SAEs or AEs leading to discontinuation Efficacy and safety findings from...
The World's Most Admired Whiskey Announces 2025 Release of Michter's 10 Year Rye
LOUISVILLE, Ky., May 20, 2025 /PRNewswire/ -- Louisville based distiller Michter's will be releasing its highly acclaimed 10 Year Kentucky Straight Rye this June. Michter's 10 Year Single Barrel Kentucky Straight Rye "Rye whiskey has deep roots in...
OTELIER ANNOUNCES NEW ALLIANCE PARTNERSHIP WITH PREFERRED HOTELS & RESORTS, THE WORLD'S LARGEST INDEPENDENT HOTEL BRAND
Otelier becomes the latest addition to Preferred Hotels & Resorts' Alliance Partner Program, providing turnkey solutions to its global portfolio of independent luxury properties BETHESDA, Md., May 20, 2025 /PRNewswire/ -- Otelier today announced...
Minghui Pharmaceutical Announces First Patient Dosed in the Phase Ⅱ Combination Study of PD-1xVEGF Bispecific and TROP-2 ADC in Advanced NSCLC
SHANGHAI, May 20, 2025 /PRNewswire/ -- Minghui Pharmaceutical, a late-stage biopharmaceutical company dedicated to developing transformative therapies in immunology and oncology, today announced that the first patient has been successfully dosed in...